Is selective therapy of recurrent nephrolithiasis possible?

Charles Y C Pak, Paul Peters, George Hurt, Melvin Kadesky, Myron Fine, David Reisman, Frank Splann, Calvin Caramela, Alan Freeman, Faye Britton, Kashayar Sakhaee, Neil A. Breslau

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

We evaluated, in 128 patients with recurrent nephrolithiasis, the efficacy of special treatment programs for some of the common causes of nephrolithiasis, chosen on the basis of their ability to correct underlying physicochemical and physiologic derangements. Therapy included sodium cellulose phosphate for 18 patients with absorptive hypercalciuria, thiazide diuretics for 27 patients with absorptive hypercalciuria and for 10 with renal hypercalciuria, orthophosphate for eight patients with hypophosphatemic absorptive hypercalciuria, allopurinol for 21 patients with hyperuricosuric calcium oxalate nephrolithiasis, thiazide and allopurinol for 26 patients with absorptive hypercalciuria with hyperuricosuria, and high fluid intake and/or low calcium diet for 22 patients with normocalciuric nephrolithiasis. Patients in all seven groups had a significant reduction in stone formation during 1.70 to 3.37 years of treatment, as compared with the pretreatment period of three years. Remission was found in 70 to 91 percent of patients and reduced stone formation rate was encountered in 88 to 100 percent. Each treatment program produced a significant decline in stone formation rate from 1.90 to 2.28 stones per year to 0.09 to 0.55 stones per year. The actual number of stones formed during treatment was significantly lower than the number predicted from the pretreatment frequency of stone formation (less than 26 percent). The results provide evidence supporting a selective approach to therapy of nephrolithiasis.

Original languageEnglish (US)
Pages (from-to)615-622
Number of pages8
JournalThe American journal of medicine
Volume71
Issue number4
DOIs
StatePublished - 1981

Fingerprint

Nephrolithiasis
Hypercalciuria
Allopurinol
Therapeutics
Thiazides
Sodium Chloride Symporter Inhibitors
Phosphates
Diet
Calcium
Kidney

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Pak, C. Y. C., Peters, P., Hurt, G., Kadesky, M., Fine, M., Reisman, D., ... Breslau, N. A. (1981). Is selective therapy of recurrent nephrolithiasis possible? The American journal of medicine, 71(4), 615-622. https://doi.org/10.1016/0002-9343(81)90214-X

Is selective therapy of recurrent nephrolithiasis possible? / Pak, Charles Y C; Peters, Paul; Hurt, George; Kadesky, Melvin; Fine, Myron; Reisman, David; Splann, Frank; Caramela, Calvin; Freeman, Alan; Britton, Faye; Sakhaee, Kashayar; Breslau, Neil A.

In: The American journal of medicine, Vol. 71, No. 4, 1981, p. 615-622.

Research output: Contribution to journalArticle

Pak, CYC, Peters, P, Hurt, G, Kadesky, M, Fine, M, Reisman, D, Splann, F, Caramela, C, Freeman, A, Britton, F, Sakhaee, K & Breslau, NA 1981, 'Is selective therapy of recurrent nephrolithiasis possible?', The American journal of medicine, vol. 71, no. 4, pp. 615-622. https://doi.org/10.1016/0002-9343(81)90214-X
Pak, Charles Y C ; Peters, Paul ; Hurt, George ; Kadesky, Melvin ; Fine, Myron ; Reisman, David ; Splann, Frank ; Caramela, Calvin ; Freeman, Alan ; Britton, Faye ; Sakhaee, Kashayar ; Breslau, Neil A. / Is selective therapy of recurrent nephrolithiasis possible?. In: The American journal of medicine. 1981 ; Vol. 71, No. 4. pp. 615-622.
@article{a6eb4ce7a63f4a8392824555c83d9bc2,
title = "Is selective therapy of recurrent nephrolithiasis possible?",
abstract = "We evaluated, in 128 patients with recurrent nephrolithiasis, the efficacy of special treatment programs for some of the common causes of nephrolithiasis, chosen on the basis of their ability to correct underlying physicochemical and physiologic derangements. Therapy included sodium cellulose phosphate for 18 patients with absorptive hypercalciuria, thiazide diuretics for 27 patients with absorptive hypercalciuria and for 10 with renal hypercalciuria, orthophosphate for eight patients with hypophosphatemic absorptive hypercalciuria, allopurinol for 21 patients with hyperuricosuric calcium oxalate nephrolithiasis, thiazide and allopurinol for 26 patients with absorptive hypercalciuria with hyperuricosuria, and high fluid intake and/or low calcium diet for 22 patients with normocalciuric nephrolithiasis. Patients in all seven groups had a significant reduction in stone formation during 1.70 to 3.37 years of treatment, as compared with the pretreatment period of three years. Remission was found in 70 to 91 percent of patients and reduced stone formation rate was encountered in 88 to 100 percent. Each treatment program produced a significant decline in stone formation rate from 1.90 to 2.28 stones per year to 0.09 to 0.55 stones per year. The actual number of stones formed during treatment was significantly lower than the number predicted from the pretreatment frequency of stone formation (less than 26 percent). The results provide evidence supporting a selective approach to therapy of nephrolithiasis.",
author = "Pak, {Charles Y C} and Paul Peters and George Hurt and Melvin Kadesky and Myron Fine and David Reisman and Frank Splann and Calvin Caramela and Alan Freeman and Faye Britton and Kashayar Sakhaee and Breslau, {Neil A.}",
year = "1981",
doi = "10.1016/0002-9343(81)90214-X",
language = "English (US)",
volume = "71",
pages = "615--622",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Is selective therapy of recurrent nephrolithiasis possible?

AU - Pak, Charles Y C

AU - Peters, Paul

AU - Hurt, George

AU - Kadesky, Melvin

AU - Fine, Myron

AU - Reisman, David

AU - Splann, Frank

AU - Caramela, Calvin

AU - Freeman, Alan

AU - Britton, Faye

AU - Sakhaee, Kashayar

AU - Breslau, Neil A.

PY - 1981

Y1 - 1981

N2 - We evaluated, in 128 patients with recurrent nephrolithiasis, the efficacy of special treatment programs for some of the common causes of nephrolithiasis, chosen on the basis of their ability to correct underlying physicochemical and physiologic derangements. Therapy included sodium cellulose phosphate for 18 patients with absorptive hypercalciuria, thiazide diuretics for 27 patients with absorptive hypercalciuria and for 10 with renal hypercalciuria, orthophosphate for eight patients with hypophosphatemic absorptive hypercalciuria, allopurinol for 21 patients with hyperuricosuric calcium oxalate nephrolithiasis, thiazide and allopurinol for 26 patients with absorptive hypercalciuria with hyperuricosuria, and high fluid intake and/or low calcium diet for 22 patients with normocalciuric nephrolithiasis. Patients in all seven groups had a significant reduction in stone formation during 1.70 to 3.37 years of treatment, as compared with the pretreatment period of three years. Remission was found in 70 to 91 percent of patients and reduced stone formation rate was encountered in 88 to 100 percent. Each treatment program produced a significant decline in stone formation rate from 1.90 to 2.28 stones per year to 0.09 to 0.55 stones per year. The actual number of stones formed during treatment was significantly lower than the number predicted from the pretreatment frequency of stone formation (less than 26 percent). The results provide evidence supporting a selective approach to therapy of nephrolithiasis.

AB - We evaluated, in 128 patients with recurrent nephrolithiasis, the efficacy of special treatment programs for some of the common causes of nephrolithiasis, chosen on the basis of their ability to correct underlying physicochemical and physiologic derangements. Therapy included sodium cellulose phosphate for 18 patients with absorptive hypercalciuria, thiazide diuretics for 27 patients with absorptive hypercalciuria and for 10 with renal hypercalciuria, orthophosphate for eight patients with hypophosphatemic absorptive hypercalciuria, allopurinol for 21 patients with hyperuricosuric calcium oxalate nephrolithiasis, thiazide and allopurinol for 26 patients with absorptive hypercalciuria with hyperuricosuria, and high fluid intake and/or low calcium diet for 22 patients with normocalciuric nephrolithiasis. Patients in all seven groups had a significant reduction in stone formation during 1.70 to 3.37 years of treatment, as compared with the pretreatment period of three years. Remission was found in 70 to 91 percent of patients and reduced stone formation rate was encountered in 88 to 100 percent. Each treatment program produced a significant decline in stone formation rate from 1.90 to 2.28 stones per year to 0.09 to 0.55 stones per year. The actual number of stones formed during treatment was significantly lower than the number predicted from the pretreatment frequency of stone formation (less than 26 percent). The results provide evidence supporting a selective approach to therapy of nephrolithiasis.

UR - http://www.scopus.com/inward/record.url?scp=0019801336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019801336&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(81)90214-X

DO - 10.1016/0002-9343(81)90214-X

M3 - Article

VL - 71

SP - 615

EP - 622

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 4

ER -